Attached files
file | filename |
---|---|
10-K - 10-K - PDL BIOPHARMA, INC. | pdli1231201710-kdoc.htm |
EX-32.1 - CERTIFICATION - PDL BIOPHARMA, INC. | pdli1231201710-kex321.htm |
EX-31.2 - CERTIFICATION - PDL BIOPHARMA, INC. | pdli1231201710-kex312.htm |
EX-31.1 - CERTIFICATION - PDL BIOPHARMA, INC. | pdli1231201710-kex311.htm |
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - PDL BIOPHARMA, INC. | pdli1231201710-kex231.htm |
EX-12.1 - RATIO OF EARNINGS TO FIXED CHARGES - PDL BIOPHARMA, INC. | pdli1231201710-kex121.htm |
EX-10.71 - EXHIBIT 10.71 - PDL BIOPHARMA, INC. | pdli1231201710-kex1071.htm |
Exhibit 21.1
SUBSIDIARIES OF THE REGISTRANT
NAME OF SUBSIDIARY OR ORGANIZATION | STATE OF INCORPORATION OR FORMATION | |
DFM, LLC | Delaware | |
LENSAR, Inc. | Delaware | |
Noden Pharma Canada ULC | Province of British Columbia | |
Noden Pharma DAC | Republic of Ireland | |
Noden Pharma Schweiz GmbH | Basel | |
Noden Pharma USA, Inc. | Delaware | |
PDL Investment Holdings, LLC | Delaware |